# Investigating Dupilumab's Effect in Asthma by Genotype

> **NCT03694158** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Boston Children's Hospital** · enrollment: 150 (estimated)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Dupilumab
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03694158
- **Lead sponsor:** Boston Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-09-08
- **Primary completion:** 2027-01
- **Final completion:** 2027-03
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-02-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03694158

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03694158, "Investigating Dupilumab's Effect in Asthma by Genotype". Retrieved via AI Analytics 2026-07-21 from https://api.ai-analytics.org/clinical/NCT03694158. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*